Reply to Aljabali et al. Comment on "Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2022, , 213".

Basel Abdelazeem Kirellos Said Abbas James Robert Brašić

Medicina (Kaunas)

Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Published: June 2022

We appreciate Ahmed Sami Aljabali and his colleagues for their interest and comments [...].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228947	PMC
http://dx.doi.org/10.3390/medicina58060793	DOI Listing

Publication Analysis

Top Keywords

reply aljabali

aljabali comment

comment "abbas

"abbas safety

safety efficacy

efficacy nusinersen

nusinersen treatment

treatment spinal

spinal muscular

muscular atrophy

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!